CDCA5
Basic information
Region (hg38): 11:65066300-65084164
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDCA5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 12 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 12 | 2 | 5 |
Variants in CDCA5
This is a list of pathogenic ClinVar variants found in the CDCA5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-65079153-T-A | not specified | Uncertain significance (Oct 19, 2024) | ||
11-65079156-A-G | not specified | Uncertain significance (Feb 01, 2025) | ||
11-65079179-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
11-65079183-G-A | not specified | Uncertain significance (Nov 23, 2021) | ||
11-65079364-G-A | not specified | Uncertain significance (May 17, 2023) | ||
11-65079377-C-T | Likely benign (Dec 31, 2019) | |||
11-65079475-A-C | not specified | Uncertain significance (Jun 26, 2024) | ||
11-65079477-C-G | not specified | Uncertain significance (Jul 14, 2024) | ||
11-65079496-C-T | Benign (Oct 17, 2018) | |||
11-65079512-C-T | Benign (Dec 31, 2019) | |||
11-65079523-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
11-65079526-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
11-65079664-C-T | Benign (Dec 31, 2019) | |||
11-65079671-A-T | Benign (Jun 05, 2018) | |||
11-65079672-G-C | not specified | Uncertain significance (Jun 03, 2024) | ||
11-65079706-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
11-65079714-T-C | not specified | Uncertain significance (Jan 16, 2025) | ||
11-65079716-T-C | Benign (Aug 17, 2018) | |||
11-65083354-G-A | Likely benign (Jan 11, 2019) | |||
11-65083390-C-A | not specified | Uncertain significance (Aug 13, 2021) | ||
11-65083956-G-T | not specified | Uncertain significance (Feb 04, 2025) | ||
11-65083969-T-C | not specified | Uncertain significance (Jul 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDCA5 | protein_coding | protein_coding | ENST00000275517 | 6 | 17865 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00116 | 0.853 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.10 | 105 | 142 | 0.741 | 0.00000774 | 1597 |
Missense in Polyphen | 39 | 50.235 | 0.77636 | 598 | ||
Synonymous | 1.16 | 46 | 57.1 | 0.805 | 0.00000327 | 525 |
Loss of Function | 1.25 | 6 | 10.4 | 0.579 | 4.37e-7 | 135 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000177 | 0.000177 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000736 | 0.0000703 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of sister chromatid cohesion in mitosis stabilizing cohesin complex association with chromatin. May antagonize the action of WAPL which stimulates cohesin dissociation from chromatin. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. Required for efficient DNA double-stranded break repair. {ECO:0000269|PubMed:15837422, ECO:0000269|PubMed:17349791, ECO:0000269|PubMed:21111234}.;
- Pathway
- MicroRNAs in cancer - Homo sapiens (human);Establishment of Sister Chromatid Cohesion;S Phase;Mitotic Prometaphase;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Resolution of Sister Chromatid Cohesion;Cell Cycle, Mitotic
(Consensus)
Intolerance Scores
- loftool
- 0.673
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.32
Haploinsufficiency Scores
- pHI
- 0.649
- hipred
- Y
- hipred_score
- 0.549
- ghis
- 0.587
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.659
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdca5
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; growth/size/body region phenotype; hearing/vestibular/ear phenotype; embryo phenotype;
Gene ontology
- Biological process
- mitotic cell cycle;double-strand break repair;mitotic sister chromatid cohesion;mitotic chromosome condensation;mitotic metaphase plate congression;positive regulation of exit from mitosis;cell division;regulation of cohesin loading
- Cellular component
- chromosome, centromeric region;nuclear chromatin;nucleus;nucleoplasm;chromosome;cytoplasm;cytosol;cohesin complex
- Molecular function
- chromatin binding;protein binding;protein-containing complex binding